Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes

Stopped Company decision taken in light of demands by certain national health authorities

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG: Rimonabant
• DRUG: Placebo (for Rimonabant)
• DRUG: Metformin

Sponsor

Sanofi